Key Highlights: Implications: With legal access to the Charpentier CRISPR/Cas9 patents, Aurigene can now run gene‑editing projects (target validation, disease models, f...
Home / CRDMO
Browsing Tag: CRDMO
Featured Posts

Your Compass In Indian Pharma
Key Highlights: Implications: With legal access to the Charpentier CRISPR/Cas9 patents, Aurigene can now run gene‑editing projects (target validation, disease models, f...